Epidemiologic data on morbidity and mortality related to acute and chronic disease states

Analyze epidemiologic data on morbidity and mortality related to acute and chronic disease states.

Individual Preventive Screening

Review the clinician provider guidelines and recommendations from the United States Preventive Services Task Force A and B Recommendations.

For the master's-prepared nurse, knowledge of epidemiology and its application to preventive screening guidelines is important in many clinical areas: administrative, education, and nurse practitioner fields.

Individual patient preventive screenings are ordered as a secondary measure before symptoms occur.

Preventive screenings are recommended based on outcome data from epidemiological studies, that the test is beneficial; based on risk and characteristics of the identified population in the screening guideline.

Select one screening below from the United States Preventive Services Task Force guidelines.

Abdominal aortic aneurysm
Breast cancer
Cervical cancer
Colon cancer
Diabetes mellitus Il
Lung cancer
Condition and Screening

• Define the condition and type of screening

Epidemiology of Condition

• Discuss the epidemiology of the condition in the United States, via three statistical terms. Include the mortality and related morbidity statistics in numerical format and address trends. Include 3 comparisons: related disparities, such as race, sex, age, etc. Clearly state an analysis of the data, identifying gaps and inequities in care. Provide trends and outcomes related to screening benefits in numerical statistics.

Methodology

Incorporate the described USPSTF guideline development methodology process, (How the guideline was developed).
Discuss the preventive guideline criteria, the population, and provide details on the screening tool.
Include detailed risk factors. If there is a risk prediction tool, include this.
Critical Analysis

Conduct a literature review of the guideline's support used for its development. You may include alternative studies found in more recent literature supporting or offering alternative views.
Identify and discuss four studies used in the guideline development clearly relating the impact on the guideline criteria for screening, tool, or population etc.
Identify each study clearly in the naner and cite
Methodology

Incorporate the described USPSTF guideline development metodology process, (How the guideline
was developed).
Discuss the preventive guideline criteria, the population, and provide details on the screening tool.

Sample Answer

Condition and Screening

Colorectal Cancer is a malignant tumor arising from the inner wall of the large intestine (colon) or rectum. It typically develops from precancerous growths called adenomatous polyps.

Type of Screening: Secondary prevention. The primary tools are stool-based tests (e.g., FIT, sDNA-FIT) or visual examinations (e.g., Colonoscopy, CT colonography). Screening aims to detect cancer at an early, asymptomatic stage or identify and remove polyps before they become malignant.

Epidemiology of Condition (United States)

The epidemiology of CRC highlights significant morbidity and mortality, alongside stark disparities.

1. Statistical Terms and Data

Incidence: In 2024, an estimated 152,810 new cases of CRC will be diagnosed. The age-adjusted incidence rate is approximately 35.0 per 100,000 persons.

Mortality: CRC remains the second leading cause of cancer death. Approximately 53,010 deaths are expected annually, with a mortality rate of roughly 12.6 per 100,000.

Prevalence: There are currently more than 1.5 million survivors of colorectal cancer in the U.S.

2. Disparities and Comparisons

Race: Black Americans have the highest incidence and mortality rates of any racial group. Incidence is roughly 20% higher, and